VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 35 filers reported holding VINCERX PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $348,275 | -22.3% | 344,827 | -0.0% | 0.00% | 0.0% |
| Q2 2023 | $448,276 | +24.8% | 344,828 | -0.1% | 0.00% | 0.0% |
| Q1 2023 | $359,129 | +2.1% | 345,316 | +0.1% | 0.00% | 0.0% |
| Q4 2022 | $351,724 | -26.1% | 344,827 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $476,000 | +4.6% | 344,827 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $455,000 | -67.0% | 344,827 | 0.0% | 0.00% | -60.0% |
| Q1 2022 | $1,379,000 | -60.8% | 344,827 | 0.0% | 0.01% | -64.3% |
| Q4 2021 | $3,514,000 | -31.6% | 344,827 | 0.0% | 0.01% | -39.1% |
| Q3 2021 | $5,138,000 | – | 344,827 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,618,199 | $31,231,000 | 10.26% |
| Affinity Asset Advisors, LLC | 543,010 | $10,480,000 | 3.56% |
| ACUTA CAPITAL PARTNERS, LLC | 394,000 | $7,604,000 | 2.74% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $9,650,000 | 2.72% |
| Logos Global Management LP | 480,000 | $9,264,000 | 0.90% |
| Sio Capital Management, LLC | 105,000 | $2,027,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 82,948 | $1,601,000 | 0.31% |
| Monashee Investment Management LLC | 99,999 | $1,930,000 | 0.30% |
| Ikarian Capital, LLC | 438,684 | $8,467,000 | 0.28% |
| RTW INVESTMENTS, LP | 500,000 | $9,650,000 | 0.15% |